Clinical Relevance of Liquid Biopsies in Metastatic Adenocarcinoma of Non-small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Chougule, A. [1 ]
Chandrani, P. [1 ]
Pange, P. [1 ]
Kale, S. [1 ]
Jagtap, V. [1 ]
Noronha, V. [1 ]
Joshi, A. [1 ]
Patil, V. [1 ]
Dutt, A. [1 ]
Prabhash, K. [1 ]
Banavali, S. [1 ]
机构：
[1] Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2019年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
G040
引用
收藏
页码：1131 / 1131
页数：1
相关论文
共 50 条
  • [21] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [22] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Li, H.
    Sun, J.
    Zhang, J.
    Fei, C.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2022, 33 : S1 - S2
  • [23] Serum metastin is not involved in metastatic potential of non-small cell lung cancer (NSCLC)
    Karapanagiotou, E. M.
    Dilana, K. D.
    Boura, P. G.
    Gratsias, I.
    Polyzos, A.
    Syrigos, K. N.
    EJC SUPPLEMENTS, 2009, 7 (02): : 519 - 519
  • [24] Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC)
    Reck, M
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1501 - 1506
  • [25] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [27] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] SOCIETAL COST SAVINGS IN METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN FRANCE
    Stanisic, S.
    Vergnenegre, A.
    Chouaid, C.
    Mueller, E.
    Walzer, S.
    VALUE IN HEALTH, 2010, 13 (07) : A271 - A271
  • [29] BURDEN OF BRAIN METASTASIS IN AN METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) POPULATION
    Ganguli, A.
    Henk, H.
    Teitelbaum, A.
    Ray, S.
    VALUE IN HEALTH, 2011, 14 (07) : A440 - A441
  • [30] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Chen, C.
    Xiang, X.
    Fei, C.
    Yang, L.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2021, 32 : S996 - S997
12345